Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Survey reveals 45% of junior doctors are considering leaving the profession

August 10, 2022 Research and Development

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …
News

Karuna Therapeutics announces positive results from Phase III trial into schizophrenia

August 10, 2022 Research and Development

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …
News

Tagrisso combined with Hutchmed drug clears lung cancer test

August 10, 2022 Research and Development

Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …
News

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility

July 27, 2022 Research and Development

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …
News

Micronesia’s first COVID outbreak sees steep rise in cases

July 27, 2022 Research and Development

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …
News

Updated NICE pre-eclampsia guidance

July 27, 2022 Research and Development

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …
News

Depression may not be caused by chemical imbalance

July 20, 2022 Research and Development

A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …
News

COVID-19 boosters to be offered to all over 50s this autumn

July 20, 2022 Research and Development

All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …
News

Potential shortage of 140,000 nurses in NHS England by 2030

July 20, 2022 Research and Development

According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …
News

TSB and CR Pharma partner for COVID-19 antibody therapy in China

July 20, 2022 Research and Development

TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …
News

Gene editing potential treatment for hereditary killer

July 13, 2022 Research and Development

Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in …
News

FDA accepts Byondis’ Biologics License Application for breast cancer treatment

July 13, 2022 Research and Development

The FDA has accepted Byondis’ submission of a Biologics License Application (BLA) for [vic-] trastuzumab duocarmazine (SYD985) in patients with …
News

Trial of mRNA first Nipah virus vaccine

July 13, 2022 Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage …
News

Health organisations warn monkeypox could become endemic in UK if action is not taken

July 13, 2022 Research and Development

Leading sexual health organisations have warned that monkeypox could become endemic in the UK if the government does not take …
News

Sajid Javid resigns as Health Secretary, Steve Barclay appointed

July 6, 2022 Research and Development

Steve Barclay former chief of staff at Number 10 Downing Street, has been appointed new Health Secretary, following the resignation …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026